Cargando…
From the Hypotheses to Clinical Evidence in Retinal Therapy
The off-label, therapeutic use of intravitreal bevacizumab (IVB) in vascular retinal diseases such as diabetic macular edema and proliferative diabetic retinopathy (PDR) has increased significantly due to its ability to reduce retinal neovascularization and slow progression of disease. Here, we will...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PUBLISHED BY KNOWLEDGE E
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126734/ https://www.ncbi.nlm.nih.gov/pubmed/34055265 http://dx.doi.org/10.18502/jovr.v16i2.9092 |